Allantoin Market Report Scope & Overview:

The Allantoin Market was valued at USD 748.90 Million in 2025 and is expected to reach USD 1.33 Billion by 2035, growing at a CAGR of 5.90% from 2026-2035.

Allantoin is a natural heterocyclic compound, a product of uric acid metabolism, and is produced commercially by chemical synthesis from glyoxylic acid and urea, or by extraction from plant sources such as comfrey root. It is highly valued for its keratolytic, moisturizing and skin-soothing properties and is a key ingredient in moisturizers, sunscreens, wound-care dressings, lip balms, shaving products and oral care formulations. It is compatible with a wide range of pH and can be mixed with other active ingredients, which favors its broad use. Growth of the market is attributed to the growing personal care and cosmetics industry, increasing demand for mild and dermatologically proven ingredients, and steady consumption in pharmaceutical and wound-care applications.

U.S. Allantoin Market Outlook

The U.S. Allantoin Market was valued at USD 158.71 Million in 2025 and is expected to reach USD 268.56 Million by 2035, growing at a CAGR of 5.40% from 2026-2035.

Demand is rooted in a robust cosmetics and personal care manufacturing industry that is centered in the states of New Jersey, Ohio, and the Carolinas, along with a robust contract manufacturing industry catering to skin protection and lip care products that are sold over the counter. The demand arising out of reformulation work related to FDA guidelines for labels means that some major national brands are opting to validate the amount of allantoin used in their stock keeping units rather than formulating new products, thereby reducing volume growth as compared to Asia-Pacific. Pharmaceutical quality demands from wound care and dermatological ointments also remain strong.

By Form, Powder Dominates the Allantoin Market and Liquid Grows Fastest

Powder is the leading form in the allantoin market, reflecting its long shelf life, ease of transport, and compatibility with a wide range of manufacturing processes used by cosmetics and pharmaceutical formulators. The powdered form of allantoin does not necessitate the need for refrigeration or climate control in its storage, and this results in reduced logistical expenses for consumers who operate numerous warehouses within various regions. The contract manufacturers also find the powdered form convenient since it is easier to add this compound in formulation batches using gravimetric dosing without the difficulties of handling viscous liquids. Multinational personal care companies that use large-scale production lines in various plants prefer the powder form of allantoin.

Liquid and pre-dispersed allantoin concentrates are the fastest-growing form, as cold-process formulators increasingly prefer ready-to-use solutions that eliminate an in-house dissolution step. Smaller and mid-sized cosmetics brands that lack dedicated high-shear mixing equipment find pre-dispersed grades easier to incorporate consistently into finished emulsions without introducing undissolved particulates.

By Source, Synthetic Dominates the Allantoin Market and Natural Grows Fastest

Synthetic allantoin, produced primarily through the reaction of glyoxylic acid with urea, is the primary supplier of this ingredient based on market share as the method offers purity in a more efficient manner and at a lesser cost than plant-based extraction. Companies that synthesize the compound in large quantities using a continuous process in China and some European countries provide the majority of worldwide capacity, ensuring a stable supply chain even during the ups and downs in the agricultural supply cycle. The pharmaceutical-grade buyer finds synthetic synthesis more appealing since the consistency in impurities per batch is ensured.

Natural, plant-derived allantoin extracted from comfrey root is the fastest-growing source category, driven by clean-beauty positioning among premium and indie cosmetics brands in Western Europe and North America. Extraction yields from comfrey root remain comparatively low, which keeps natural-source allantoin priced at a notable premium over synthetic material, but brand owners marketing botanically sourced formulations have shown willingness to absorb the added cost to support ingredient-transparency claims on product packaging aimed at environmentally conscious consumers. Agricultural suppliers of comfrey root in parts of Eastern Europe have begun exploring contract-growing arrangements with ingredient manufacturers to stabilize future harvest volumes and reduce the year-to-year yield swings that have historically constrained natural-source supply.

By Application, Cosmetics & Personal Care Dominates the Allantoin Market and Pharmaceuticals Grows Fastest

Cosmetics and Personal Care is the leading application for allantoin, accounting for the largest share of global consumption as the ingredient is formulated into moisturizers, sunscreens, lip balms, shaving creams, and anti-aging serums marketed on gentleness and barrier-support claims. Mass-market skin care brands rely on allantoin as a low-cost, well-tolerated soothing agent that allows them to make sensitive-skin claims without the formulation complexity associated with newer specialty actives, which keeps repeat-purchase volumes stable across both developed and emerging consumer markets.

Pharmaceuticals is the fastest-growing application, supported by rising use of allantoin in over-the-counter wound-care ointments, diaper-rash treatments, and prescription dermatological preparations for conditions such as psoriasis and eczema. Aging population in advanced economies is responsible for the growing per capita consumption of topical wound management products, and the procurement by hospitals and care facilities of allantoin-containing skin protection preparations continues to grow steadily due to the increasing standardization of procedures for pressure injury prevention.

⮞In March 2026, Yantai Aien Biotechnology introduced its Advanced Bed Sore Wound Healing Allantoin Gel in the U.S. OTC market, containing 0.5% allantoin as its active skin-protectant ingredient for relieving chapped and cracked skin.

By Type, Pure Allantoin Dominates the Allantoin Market and Allantoin Derivatives Grows Fastest

Pure Allantoin remains the dominant product type purchased by downstream formulators, as it offers maximum formulation flexibility and allows brand chemists to control inclusion levels precisely alongside complementary actives of their own choosing. Pharmaceutical-grade pure allantoin in particular commands a price premium justified by the additional purification and testing required to meet topical drug-product specifications, and large contract manufacturers serving regulated markets continue to specify pure-grade material as their standard input. Established cosmetics brands with in-house formulation chemists also tend to purchase pure-grade material by default, since it lets them combine allantoin with other actives at ratios tailored to each product line rather than accepting a fixed blend set by an outside ingredient supplier.

Blended allantoin derivative complexes, which combine allantoin with complementary actives such as panthenol or bisabolol in a single pre-formulated ingredient, represent the fastest-growing product type as suppliers package multi-functional actives to simplify customer formulation work. Smaller cosmetics brands without large research and development teams are adopting these pre-blended complexes to shorten development timelines and reduce the number of discrete raw materials they must source, qualify, and manage across their supply chains. Ingredient suppliers marketing these complexes typically bundle technical formulation support alongside the product itself, a service model that appeals strongly to smaller brands operating without dedicated in-house chemistry staff of their own.

Regional Analysis

North America Allantoin Market Insights

North America is the third-largest regional market, with an estimated 24.50% share in 2025 and a projected CAGR of approximately 5.30% from 2026 to 2035, anchored by a mature cosmetics manufacturing base in the United States alongside steady pharmaceutical-grade demand from wound-care product manufacturers. Canada contributes a smaller but stable share of regional consumption, driven primarily by personal care contract manufacturers serving both local retail brands and export customers in the broader North American market. Regional growth is moderated by the comparatively saturated state of the mass cosmetics category, where reformulation activity tends to substitute allantoin into existing stock-keeping units rather than drive incremental volume through entirely new product launches.

Regulatory developments under the Modernization of Cosmetics Regulation Act are prompting brand owners across the region to revisit ingredient documentation and safety substantiation practices, adding administrative overhead without materially changing underlying formulation volumes. Contract manufacturers in the United States and Mexico continue to expand capacity to serve nearshoring customers seeking shorter supply chains than those running through Asia Pacific producers, a trend that is expected to support modest additional allantoin throughput over the remainder of the forecast period without altering the region's overall competitive structure.

⮞In June 2026, Austrian skincare company RINGANA announced an USD 85 million investment to establish its first U.S. headquarters, production and distribution facility in Roanoke, Virginia, creating 435 jobs and expanding regional skincare manufacturing capacity.

Asia Pacific Allantoin Market Insights

With a share of 39.50% in 2025, Asia Pacific led the market and is also the fastest-growing region, with a projected CAGR of 6.85% from 2026 to 2035, supported by China's position as the leading global producer of synthetic allantoin and by rapidly expanding cosmetics manufacturing capacity across India, South Korea and Southeast Asia. China's cosmetics consumption continues to grow even as several large Chinese personal care brands have faced slower sales growth in recent reporting periods, with formulation activity remaining resilient even where topline brand revenue softens. Regulatory adjustments to China's Cosmetic Ingredients catalogue are reshaping how allantoin suppliers document and register their materials for sale into that market.

India has emerged as a particularly active growth pocket within the region, with growing domestic cosmetics manufacturing and rising demand for natural and specialty actives serving both local and export customers. Japan and South Korea continue to serve as innovation centers for premium skin care formulations incorporating allantoin alongside other barrier-support actives and several Japanese personal care majors have reported improved profitability even amid a broader slowdown in Chinese retail demand, underscoring the region's layered growth dynamics across different national markets.

⮞In August 2026, Guangzhou Datang Cosmetics began construction of an intelligent manufacturing facility in Conghua, Guangdong, designed for functional skincare, haircare and household products, with planned annual production capacity of 36,000 tonnes and approximately 600 jobs.

Europe Allantoin Market Insights

Europe is the second-largest regional market, with a 27.00% share in 2025 and a projected CAGR of approximately 5.10% from 2026 to 2035, with demand driven by clean-beauty and natural-ingredient positioning among cosmetics brands based in Germany, France, and the Nordic countries. European regulatory frameworks governing cosmetic ingredient safety and labeling are generally viewed by multinational brand owners as a benchmark standard, which has encouraged several global cosmetics companies to pilot allantoin-forward reformulations in European markets before extending them elsewhere. Specialty chemicals manufacturers headquartered in Germany and Switzerland also hold a large share of European allantoin production capacity relative to the region's share of global cosmetics consumption, giving regional formulators preferential access to newly developed grades ahead of overseas customers.

Natural and plant-extracted allantoin sourced from comfrey root finds a particularly receptive customer base in Western Europe, where premium skin care brands market ingredient transparency as a core differentiator against mass-market competitors. Dermocosmetic brands distributed through pharmacy channels in France, Germany, and the Nordic region continue to expand their allantoin-containing product lines, supported by consumer trust in pharmacy-channel skin care that is somewhat distinct from the purely retail-driven cosmetics markets found in North America and parts of Asia Pacific.

⮞In July 2026, BASF inaugurated a new production plant in Düsseldorf, Germany, following a mid-double-digit-million-euro investment to expand specialty emollient manufacturing capacity for European and global skincare and sun-protection formulations.

MEA & Latin America Allantoin Market Insights

The Middle East & Africa represents a smaller but a gradually increasing region of consumption for allantoin, with a projected share of about 5.00% and a CAGR of roughly 6.20% between 2026 and 2035, mainly due to growth in countries of the Gulf Cooperation Council owing to increased investment in domestic production capacity in cosmetics manufacturing industry as opposed to import of finished products. The government initiatives in Saudi Arabia and UAE toward the diversification of their economies have been instrumental in promoting local manufacturing of personal care products and, therefore, demand for incremental allantoin in the region.

Latin America represented a smaller 4.00% share in 2025 and is projected to grow at a CAGR of approximately 5.50% from 2026 to 2035, with Brazil as the region's largest national market given its sizeable cosmetics industry and well-established natural-ingredient positioning among local personal care brands. For smaller regional formulators that rely on import-dependent sources for ingredients, currency volatility in some Latin American economies remains a challenge. As such, some manufacturers are choosing to use locally produced or regionally sourced allantoin when available, rather than committing to longer-lead-time imports from Asia Pacific producers.

⮞In March 2026, Lubrizol inaugurated its Beauty Research Institute in São Paulo, establishing a dedicated research and development center with integrated application laboratories and clinical-testing capabilities to accelerate skincare and haircare ingredient innovation for global personal-care markets.

Market Dynamics

Growth Drivers: Expanding cosmetics reformulation activity is sustaining steady allantoin demand

The steady reformulation of mass and masstige cosmetics products around dermatologically validated, well-tolerated active ingredients is a primary driver of allantoin demand, as brand owners seek to support gentleness and sensitive-skin marketing claims without introducing formulation complexity or added regulatory risk. Allantoin's long history of safe topical use and its compatibility with a wide range of other actives make it a low-risk choice for brands updating existing stock-keeping units rather than developing entirely new formulations from scratch, which keeps adoption costs low relative to newer, less-established specialty actives.

A second driver is merger and acquisition activity among personal care ingredient and finished-brand companies, as acquirers typically expand distribution of allantoin-containing product lines into new geographies following a deal rather than discontinuing them. Continued consumer demand for accessible, everyday skin care products that make credible gentleness claims is expected to sustain reformulation-driven allantoin consumption growth across both developed and emerging markets throughout the remainder of the forecast period, even as individual brand portfolios shift through ongoing industry consolidation and changing ownership structures.

⮞In June 2025, TAGRID LLC introduced its Bed Sore and Wound Healing Cream in the U.S. OTC market, featuring 0.5% allantoin as its active skin protectant for minor cuts, scrapes, burns and pressure-ulcer-associated skin irritation.

Restraints: Feedstock and raw material price volatility pressures producer margins

Allantoin production costs are sensitive to fluctuations in the price of glyoxylic acid and urea, the principal feedstocks used in synthetic manufacturing, and periodic volatility in these upstream chemical markets can compress margins for allantoin producers or force price increases that downstream formulators must absorb. Smaller specialty ingredient suppliers with limited feedstock purchasing power are more exposed to this volatility than large, vertically integrated chemical manufacturers, creating a competitive disadvantage that has contributed to continued consolidation among mid-sized producers over recent years.

A second restraint is that natural, plant-extracted allantoin faces a related but distinct constraint, as comfrey root extraction yields are inherently limited and subject to agricultural seasonality, keeping natural-source material priced at a persistent premium that restricts its adoption to premium and indie brand segments willing to absorb higher input costs. Large multinational ingredient suppliers with diversified specialty chemicals portfolios are generally better positioned to manage this volatility than narrowly focused allantoin producers, reinforcing scale advantages across the competitive landscape.

Opportunities: Emerging-market natural ingredient innovation is widening the addressable market

Rising investment in natural and specialty cosmetics ingredient development across emerging markets, particularly in India and other parts of South Asia, represents a meaningful opportunity for allantoin suppliers willing to partner with regional formulators on tailored natural-source or blended-derivative products. Venture-backed cosmetics ingredient companies in these markets are scaling production and distribution networks aimed at both local consumption and export to developed markets, creating new downstream demand channels that established multinational suppliers have only begun to serve directly. Local funding rounds are also lowering the capital barrier for smaller formulation houses to commercialize allantoin-forward product lines.

A second opportunity lies in suppliers developing pre-blended allantoin derivative complexes tailored to the specific formulation needs of smaller, resource-constrained cosmetics brands, which stand to capture disproportionate growth as the indie and masstige beauty segment continues to expand its share of overall personal care spending. Partnerships between established chemical manufacturers and emerging-market ingredient innovators are expected to accelerate over the next several years as both sides seek to combine production scale with localized formulation expertise and regional regulatory knowledge built up over years of operating in these markets.

⮞In May 2026, Solésence commercially launched its patented WHSPR™ allantoin delivery technology, enabling stable, high-concentration allantoin incorporation into anhydrous serums, balms and facial and lip oils, expanding formulation opportunities across skincare, suncare and color cosmetics.

Allantoin Market Key Players

• Clariant AG

• Ashland Inc.

• Merck KGaA

• Wuhu Huahai Biology Co., Ltd.

• Shandong Ailitong New Materials Co., Ltd.

• Akema Fine Chemicals S.r.l.

• Rita Corporation

• Allan Chemical Corporation

• Shaanxi Rebecca Bio-Tech Co., Ltd.

• Symrise AG

• Xi'an Lyphar Biotech Co., Ltd

Allantoin Market Report Scope: